BD Vacutainer Blood Collection Tubes Recalled for Excess Anticoagulant
Becton Dickinson is recalling specific lots of BD Vacutainer blood collection tubes because they contain approximately twice the expected amount of buffered sodium citrate additive.
The agency’s classification
FDA (Devices): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a manufacturing deviation (excess anticoagulant) without reported injuries or illnesses, fitting the criteria for a moderate severity voluntary precautionary recall.
Plain-English summary
Becton Dickinson & Company is recalling a portion of Lot 6090572 of BD Vacutainer Buffered Sodium Citrate Blood Collection Tubes (Catalog Number 369714). The recall involves 1,488,800 tubes that were distributed worldwide, including the United States, Canada, Mexico, and Indonesia.
The recall was initiated because a portion of this lot was manufactured with approximately twice the expected amount of buffered sodium citrate additive, which functions as an anticoagulant. These tubes are used to collect, transport, and process blood for clinical laboratory coagulation assays and determinations.
The source text does not specify specific actions for consumers or healthcare providers beyond the recall notice itself. Users of these specific tubes should verify their lot numbers against the recall information provided by the manufacturer or the FDA.
The recalled product
- Product
- BD Vacutainer Buffered Sodium Citrate: (9NC) Blood Collection Tube (4.5 ml x 13 x 75 mm) Catalog Number: 369714 Product Usage: The BD Vacutainer Safety Coagulation tube is an evacuated blood collection tube that provides means of collecting, transporting and processing…
- Manufacturer
- Becton Dickinson & Company
- Affected units
- 1,488,800
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot 6090572
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Becton Dickinson & Company
See all →- SevereBD Quincke spinal trays recalled over Huons bupivacaine quality issues
FDA (Devices) · 2026-06-10
- SevereBD Whitacre 24 gauge spinal trays recalled over bupivacaine quality issues
FDA (Devices) · 2026-06-10
- SevereBD Whitacre 22G spinal trays recalled in Huons bupivacaine sub-recall
FDA (Devices) · 2026-06-10
- SevereBD Whitacre spinal trays across nine catalog numbers recalled over bupivacaine
FDA (Devices) · 2026-06-10
- SevereBD spinal trays recalled as a sub-recall of Huons bupivacaine
FDA (Devices) · 2026-06-10
Similar recalls
- HighBD Vacutainer Blood Collection Tubes Recalled for Stopper Pullout Risk
FDA (Devices) · 2017-04-12
- ModerateBD Vacutainer Plus Plastic Citrate Blood Collection Tubes Recalled for Overfill
FDA (Devices) · 2018-06-27
- HighBD Vacutainer Citrate Blood Collection Tubes Recalled for Test Errors
FDA (Devices) · 2013-02-06
- ModerateBD Vacutainer Blood Collection Tubes Recalled for Incorrect Labeling
FDA (Devices) · 2017-11-15
- HighBD Vacutainer PLUS K2EDTA Tubes Recalled for Insufficient Additive
FDA (Devices) · 2016-01-06
- HighBD Vacutainer K2EDTA Tubes Recalled for Insufficient Additive
FDA (Devices) · 2016-01-06